Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 40 and up Women only

Hormone Replacement Therapy added to standard care for frozen shoulder in peri- or postmenopausal women

Official title: Hormone Replacement Therapy as an Adjunct Treatment for Adhesive Capsulitis of the Shoulder (Frozen Shoulder) in Peri- and Postmenopausal Women

Run by University of California, San Francisco · NCT07278323 · Data updated 2026-11-12

This study tests whether adding hormone replacement therapy to standard treatment helps reduce pain and stiffness from frozen shoulder in peri- or postmenopausal women.

More Frozen Shoulder trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages40 Years and up
SexWomen only
Enrollment60 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Locations1 site (San Francisco, California)
StatusRecruiting
StartedJanuary 15, 2026
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJune 8, 2026
Trial IDNCT07278323 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women who are peri- or postmenopausal with a diagnosis of adhesive capsulitis seeking standard care for frozen shoulder.

Probably not a fit

Participants who do not respond to hormonal treatment or who experience adverse effects may not derive additional benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, phase 4 trial compares hormone replacement therapy plus standard care to standard care alone for adhesive capsulitis in peri- or postmenopausal women. All participants receive physical therapy and a joint steroid injection; the experimental group also uses an HRT patch and daily pill. Outcomes include patient-reported shoulder function, range of motion, and a motion-analysis assessment over six months. The study aims to determine if hormonal support can improve pain, mobility, and daily function beyond standard care. Sixty eligible women will be enrolled and followed prospectively at UCSF.

Why it matters

Potential benefit: If successful, participants receiving HRT may experience greater improvements in shoulder pain and motion compared with standard care alone.

How similar studies have gone: Previous research has explored hormonal influences on shoulder pathology, but this specific HRT adjunct for frozen shoulder is novel and its efficacy remains to be demonstrated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of adhesive capsulitis of the shoulder

Exclusion Criteria:

* History of hormone sensitive cancer
* Bilateral adhesive capsulitis of the shoulder
* Currently using hormonal treatments including contraceptives

Where it's running

  • UCSF Orthopaedic Institute
    San Francisco, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.